6241 results about "Small particles" patented technology

A multiparticulate, modified release composition for oral administration has been developed. The formulation is made by complexing a drug with an ion-exchange resin in the form of small particles, typically less than 150 microns. The present invention provides novel extended release coated ion exchange particles comprising drug-resin complexes, produced by binding the salt form of the drug, that do not require impregnating agents to insure the integrity of the extended release coat. To prepare a modified release formulation, one or more of the following types of particles are formulated into a final dosage form: (a) Immediate release particles, (b) Enteric coated particles, (c) Extended release particles, (d) Enteric coated-extended release particles; and (e) Delayed release particles. The various drug-containing particles described above can be further formulated into a number of different easy-to-swallow final dosage forms including, but not limited to, a liquid suspension, gel, chewable tablet, crushable tablet, rapidly dissolving tablet, or unit of use sachet or capsule for reconstitution

A method of creating small particles by a technology referred to here as “violent focusing” is disclosed, along with devices for generating such violent focusing. In general, the method comprises the steps of forcing a first fluid out of an exit opening of the feeding channel to create a fluid stream. The exit opening is positioned such that the fluid flowing out of the channel flows toward and out of an exit orifice of a pressure chamber which surrounds the exit opening of the feeding channel, and is filled with an atomizing fluid. An atomizing fluid such as a gas is directed towards the first fluid stream in approximately orthogonal directions and surrounding the circumference of the first fluid stream from all sides. The first fluid flow is broken into particles which have dimensions which are smaller than the dimensions of this fluid stream.

Powder batches of pharmaceutically-active particles and methods for making same. The pharmaceutically-active particles have a small particle size and a narrow particle size distribution and are particularly useful in devices such as medical inhalers. The present invention also provides an aerosol-based method for producing pharmaceutically-active particles wherein an aerosol is produced having a tightly controlled droplet size to produce pharmaceutically-active particles having a small particle size and narrow particle size distribution.

The present invention provides a system and a method for the production of microparticles and nanoparticles of materials that can be dissolved. The system and method of the present invention provide quicker freezing times, which in turn produces a more uniform distribution of particle sizes, smaller particles, particles with increased porosity and a more intimate mixing of the particle components. The system and method of the present invention also produce particles with greater surface area than conventional methods. One form of the present invention provides a method for the preparation of particles. An effective ingredient is mixed with water, one or more solvents, or a combination thereof, and the resulting mixture is sprayed through an insulating nozzle located at or below the level of a cryogenic liquid. The spray generates frozen particles.

This invention relates to oral care compositions comprising a basic amino acid or salt thereof, and a small particle fraction: and to methods of using and of making these compositions.

A flow cytometer includes an optical flow cell through which particles to be characterized on the basis of at least their respective side-scatter characteristics are caused to flow seriatim. A plane-polarized laser beam produced by a laser diode is used to irradiate the particles as they pass through a focused elliptical spot having its minor axis oriented parallel to the particle flow path. Initially, the plane of polarization of the laser beam extends perpendicular to the path of particles through the flow cell. A half-wave plate or the like is positioned in the laser beam path to rotate the plane of polarization of the laser beam so that it is aligned with the path of particles before it irradiated particles moving along such path.

Drug delivery balloons have densely packed crystals of small particle size of the drug thereon. An amorphous drug coating is applied to a balloon surface and annealed to provide the crystals. The balloon surface is nucleated to induce formation of drug crystals in the annealing step to provide the crystals in high density with small size.

An oral delivery system for Class II drugs that have low oral bioavailability due to their insolubility in water and slow dissolution kinetics and method for making such a drug delivery system are disclosed herein. The formulation may be a controlled release or immediate release formulation. The immediate release formulation contains a Class II drug, together with a hydrophobic polymer, preferably a bioadhesive polymer. In one embodiment, the drug and polymer are co-dissolved in a common solvent. The solution is formed into small solid particles by any convenient method, particularly by spray drying. The resulting particles contain drug dispersed as small particles in a polymeric matrix. The particles are stable against aggregation, and can be put into capsules or tableted for administration. The controlled release formulations contain a BCS Class II drug and a bioadhesive polymer. The controlled release formulations may be in the form of a tablet, capsules, mini-tab, microparticulate, or osmotic pump. Enhancement of oral uptake of the drug from use of bioadhesive polymers occurs through (1) increased dissolution kinetics due to stable micronization of the drug, (2) rapid release of the drug from the polymer in the GI tract; and (3) prolonged GI transit due to bioadhesive properties of the polymers. The combination of these effects allows the preparation of a compact, stable dosage form suitable for oral administration of many class II drugs.

A gas separation process uses a structured particulate bed of adsorbent coated shapes/particles laid down in the bed in an ordered manner to simulate a monolith by providing longitudinally extensive gas passages by which the gas mixture to be separated can access the adsorbent material along the length of the particles. The particles can be laid down either directly in the bed or in locally structured packages/bundles which themselves are similarly oriented such that the bed particles behave similarly to a monolith but without at least some disadvantages. The adsorbent particles can be formed with a solid, non-porous core with the adsorbent formed as a thin, adherent coating on the exposed exterior surface. Particles may be formed as cylinders/hollow shapes to provide ready access to the adsorbent. The separation may be operated as a kinetic or equilibrium controlled process.

A nanoparticle sensor is capable of detecting and recognizing single nanoparticles in an aqueous environment. Such sensor may find applications in broad areas of science and technology, from the analysis of diesel engine emissions to the detection of biological warfare agents. Particle detection is based on interferometric detection of multi-color light, scattered by the particle. On the fundamental level, the detected signal has a weaker dependence on particle size (ÿ R³), compared to standard detection methods (ÿ R⁶). This leads to a significantly larger signal-to-noise ratio for smaller particles. By using a multi-color or white excitation light, particle dielectric properties are probed at different frequencies. This scheme samples the frequency dependence of the particle's polarizability thereby making it possible to predict the composition of the particle material. The detection scheme also employs a heterodyne or pseudoheterodyne detection configuration, which allows it to reduce or eliminate noise contribution from phase variations, which appear in any interferometric measurements.

Polycrystalline compacts include smaller and larger hard grains that are interbonded to form a polycrystalline hard material. The larger grains may be at least about 150 times larger than the smaller grains. An interstitial material comprising one or more of a boride, a carbide, a nitride, a metal carbonate, a metal bicarbonate, and a non-catalytic metal may be disposed between the grains. The compacts may be used as cutting elements for earth-boring tools such as drill bits, and may be disposed on a substrate. Methods of making polycrystalline compacts include coating smaller hard particles with a coating material, mixing the smaller particles with larger hard particles, and sintering the mixture to form a polycrystalline hard material including interbonded smaller and larger grains. The sizes of the smaller and larger particles may be selected to cause the larger grains to be at least about 150 times larger than the smaller grains.

A thermotunneling converter is disclosed comprising a pair of electrodes having inner surfaces substantially facing one another, and a spacer or plurality of spacers positioned between the two electrodes, having a height substantially equal to the distance between the electrodes, and having a total cross-sectional area that is less than the cross-sectional area of either of the electrodes. In a preferred embodiment, a vacuum is introduced, and in a particularly preferred embodiment, gold that has been exposed to cesium vapor is used as one or both of the electrodes. In a further embodiment, the spacer is made of small particles disposed between the electrodes. In a yet further embodiment, a sandwich is made containing the electrodes with an unoxidized spacer. The sandwich is separated and the spacer is oxidized, which makes it grow to a required height whilst giving it insulatory properties, to allow for tunneling between the electrodes.

A preloaded cathode layer, comprising: (A) An integral porous structure having massive surfaces greater than 100 m²/g or pores with a size from 1.0 nm to 100 nm, wherein multiple conductive particles, platelets or filaments, without a conductive filler, form a 3-D conductive network; and (B) a metal polysulfide preloaded in the pores or deposited on the massive surfaces, selected from: (a) an M_xS_y, (x=1-3 and y=1-10) wherein M is a metal element selected from a non-lithium alkali metal, an alkaline metal selected from Mg or Ca, a transition metal, a metal from groups 13 to 17, or a combination thereof, or (b) Li₂S₆, Li₂S₇, Li₂S₈, Li₂S₉, or Li₂S₁₀, wherein the metal polysulfide contains a thin coating or small particles with a thickness or diameter less than 20 nm and occupies a weight fraction of from 1% to 99%.

The instrument has an original cleaning system, which includes a gas nozzle supplying a gas jet onto the optical surface under high pressure. This pressure is sufficient to enable the gas jet to be a single cleaning means for cleaning the optical surface in all clinical instances. A safety means prevents the patient's internal organs from barotrauma by the gas jet and includes a gas jet catcher and a suction pump of ejection type. The latter is arranged in the instrument's handle and can be used also for the removal of abundant secretions or body's small particles from the patient's cavity. Besides, the gas jet and the suction pump along with a control means form the system for pressure control within the patient's cavity.

A two-step chemical precipitation process involving hydroxide precipitation and sulfide precipitation combined with “field separation” technology such as magnetic separation, dissolved air flotation, vortex separation or expanded plastics flotation, effectively removes chelated and non-chelated heavy metal precipitates and other fine particles from water. In the first-step, the non-chelated heavy metals are precipitated as hydroxides and removed from the water by a conventional liquid/solids separator such as an inclined plate clarifier to remove a large percentage of the dissolved heavy metals. The cleaned water is then treated in a second precipitation step to remove the residual heavy metals to meet discharge limits. In the second precipitation step, any metal precipitant more effective than hydroxide for metal precipitation can be used. The invention improves metal removal, lowers cost because fewer chemicals are used, produces less sludge, and reduces the discharge of toxic metals and metal precipitants to the environment.

The invention relates to a preparation method for preparing nano-scale oxidized zinc powder with high conductivity. The method simultaneously drip mixed salt solution of zincic soluble salt and doping elements such as aluminum, gallium, indium, Yt, scandium, tin, germanium, silicon, as well as precipitating agent into water, to generate coprecipitation to generate doped zinc bloom precursor basic zinc carbonate in condition of controlling temperature and PH value of entire reaction system, and at last, calcining the product in mixed gas atmospheres of hydrogen gas and argon gas, doped superfine zinc bloom conductive powder material can be obtained. The powder material prepared by the invention has small particle-size, uniform grain fineness distribution, and which mean particle diameter is about 10 to 80 nanometer. The electric volume resistivity of the powder can reach 2.5*10^-3 omega.cm, thus its electro conductivity is better than the sample prepared by plasma method and gas-phase method in current market. The preparation method further enhances whiteness degree and conductivity of the oxidized zinc powder, and further reduces the cost.

A vascular or endoluminal stent is adapted to be implanted in a vessel, duct or tract of a human body to maintain an open lumen at the site of the implant. The sidewall of the open-ended tubular structure of the stent is a base layer of a metal biologically compatible with blood and tissue of the human body. An intermediate metal particle layer of substantial greater radiopacity overlies the base layer, with particles bonded to the base layer and to each other to leave interstices therebetween as a repository for retaining and dispensing drugs or other agents for time release therefrom after the stent is implanted, to assist the stent in maintaining the lumen open. The particles are composed primarily of a noble metal—an alloy of platinum-iridium. The sidewall has holes extending therethrough, and the particle layer resides along the outward facing and inward facing surfaces, and the edges of the through holes and open ends of the sidewall. The larger particles are bonded to surfaces of the sidewall and progressively smaller particles are bonded to those and to each other up to the outer portion of the particle layer. Exposed surfaces of the particle layer are coated with ceramic-like iridium oxide or titanium nitrate, as a biocompatible material to inhibit irritation of tissue at the inner lining of the vessel when the stent is implanted. One or more anti-thrombotic, anti-platelet, anti-inflammatory and/or anti-proliferative drugs are retained in the interstices, together with a biodegradable carrier for time release therefrom. In an alternative embodiment, the intermediate layer is solid and the biodegradable carrier and drugs or agents therein are applied to the surface of the ceramic-like coating. Gene transfer is alternatively used to control tissue proliferation.

An integrated microelectronic sensor is provided in a disposable flow membrane sensing device. The integrated sensors detect electromagnetic effect labels in flow detection zones above the sensor in the membrane. The labels are small particles that give off a detectable electromagnetic signal. They are commonly used for isolating and quantifying biochemical targets of interest. The sensors are fabricated using planar integrated circuit technologies. Sensors can detect labels of several types including magnetic, electric, and photonic. These types all have in common the fact that the sensor detects the label at a distance. Magnetoresistive sensors for detecting magnetic labels, and photodiodes for detecting photonic labels are described.

A system for using the sensors is described. There are disposable cartridges with a backing that supports the sensors and membrane is described. The integrated sensor in the cartridge is designed to be discarded after use. Also, label excitation sources are provided. The multi sensor array chip can be configured in order to detect labels in multiple zones, and to monitor progress of flow down a strip of membrane. These multiple label detection zones, using sandwich assay techniques, can quantify analyte concentration for many types of analytical samples. Also, the membrane can be micropatterned in order to provide multiple or unusually shaped flow paths.

A system and method of in vivo detection and quantification of one or more analytes. Small particles comprising a surface-active monolayer coating are embedded in the dermis. The surface-active monolayer acts to pre-concentrate the analyte by adsorbing the analyte from bulk solution. The concentrated analyte is more readily detected and quantified by one or more spectroscopic methods such as Raman spectroscopy

The invention relates to a fluorosilicone material for a super-hydrophobic coating and its preparation method and use method. The fluorosilicone material is prepared from fluorinated nano-silica and/or nano-titanium dioxide sol having two particle sizes. The fluorinated nano-silica or nano-titanium dioxide sol having the small particle size has the average particle size of 10 to 150nm. The fluorinated nano-silica or nano-titanium dioxide sol having the large particle size has the average particle size of 200 to 500nm. Through utilization of fluorine-containing siloxane in silica and/or titanium dioxide preparation, surface energy of the fluorosilicone material as a coating is effectively reduced. Through utilization of non-fluorinated dichlorodialkylsilane, coating surface hydrophily is partly reduced and a fluorine-containing silane use amount and a cost are reduced.

The present invention is an electrostatic collector for low cost, high throughput, high efficiency sampling and concentration of bioaerosols. The device is small enough to be portable and can be contained within or placed on the wall of a typical office or hospital building. The collector comprises one or more collector modules, each having an ionizing electrode, a conical outer electrode, a wet collection electrode, and a liquid collection system. Airflow through a collector module may be partially blocked to enhance the collection of smaller particles and the collection electrode may comprise multiple, programmable electrodes to focus particle deposition onto a smaller area. Particles are collected into a small volume of liquid to facilitate subsequent analysis by an attached analyzer or at a remote site.